News
HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $8 Price Target
9 May 24
News, Price Target, Reiteration, Analyst Ratings
Karyopharm Therapeutics Q1 2024 GAAP EPS $(0.32) Beats $(0.33) Estimate, Sales $33.126M Miss $34.473M Estimate
8 May 24
Earnings, Earnings Beats, Earnings Misses, News
Karyopharm Announces Presentations In Endometrial Cancer And Myelofibrosis At The 2024 American Society Of Clinical Oncology Annual Meeting
24 Apr 24
Biotech, News, General
Onco360 Selected As The Preferred National Specialty Pharmacy Partner For Karyopharm's Product XPOVIO, A First-In-Class, XPO-1 Inhibitor
13 Mar 24
Biotech, News, General
HC Wainwright & Co. Maintains Buy on Karyopharm Therapeutics, Lowers Price Target to $8
1 Mar 24
News, Price Target, Analyst Ratings
Karyopharm Therapeutics Q4 2023 GAAP EPS $(0.36) Misses $(0.30) Estimate, Sales $33.75M Miss $35.40M Estimate
29 Feb 24
Earnings, Earnings Misses, News
Earnings Scheduled For February 29, 2024
29 Feb 24
Earnings
Karyopharm Therapeutics's Earnings: A Preview
28 Feb 24
Earnings
Press releases
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
8 May 24
Earnings, Press Releases
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
8 May 24
Offerings, Press Releases
Karyopharm to Report First Quarter 2024 Financial Results on May 8, 2024
2 May 24
Press Releases
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
24 Apr 24
Press Releases
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Apr 24
Press Releases
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)
13 Mar 24
Press Releases
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Mar 24
Press Releases
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
29 Feb 24
Earnings, Press Releases
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
22 Feb 24
Press Releases